mortality/aging
• homozygous mice always die at birth; mutant embryos are alive at E19.5, as shown by spontaneous movements in the womb
|
embryo
• detectable decreased size of homozygous embryos is observed beginning at E13.5
|
• poor compared to wild-type or heterozygous embryos
|
• extramedullary hematopoiesis in the liver is largely impaired; mutants have ~50% fewer red blood cell precursors, resulting in peripheral pancytopenia with very few circulating red blood cells and virtual absence of white blood cells and platelets
|
growth/size/body
• detectable decreased size of homozygous embryos is observed beginning at E13.5
|
respiratory system
• lungs are deficient in pre-alveoli and have thick mesenchyme at E19.5, indicating a delay in development
|
• thick mesenchyme at E19.5
|
• at E19.5, embryos have lung weight:body weight ratio that is only 65% of wild-type
|
• lungs are noticeably smaller
|
hematopoietic system
• poor compared to wild-type or heterozygous embryos
|
• extramedullary hematopoiesis in the liver is largely impaired; mutants have ~50% fewer red blood cell precursors, resulting in peripheral pancytopenia with very few circulating red blood cells and virtual absence of white blood cells and platelets
|
pale spleen
(
J:121378
)
• spleen is pale suggestive of defective hematopoiesis
|
immune system
pale spleen
(
J:121378
)
• spleen is pale suggestive of defective hematopoiesis
|
liver/biliary system
pale liver
(
J:121378
)
• suggestive of defective hematopoietic system
|
cellular
• cell doubling rate of MEFs during log phase is significantly decreased compared to wild-type or heterozygous cells; doubling time during log phase is 60 hours compared to 41 and 44 hours for heterozygous and wild-type MEFs
|
• rate of DNA ligation of nuclear extracts from mouse embryonic fibroblasts in culture is 50% decreased compared to wild-type or heterozygous MEF nuclear extracts
|